A smart and versatile theranostic nanomedicine platform based on nanoporphyrin

Yuanpei Li, Tzu‐yin Lin, Yan Luo, +13

Nature Communications

NanomedicineEngineeringNanobiotechnologyNano-drug DeliveryBiomedical Engineering +1

Synthesis of ⁶⁴Cu-Labeled Magnetic Nanoparticles for Multimodal Imaging

Benjamin R. Jarrett, Björn Gustafsson, David L. Kukis, +1

Bioconjugate Chemistry

NanoparticlesEngineeringCombined Magnetic ResonanceMetal NanoparticlesImaging Agent +23

Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent.

S.V. Deshpande, Sally J. DeNardo, David L. Kukis, +4

PubMed

ImmunologyBiological TherapyImmunotherapeuticsImmunotherapyTumor Uptake +16

A Novel Method to Label Preformed Liposomes with ⁶⁴Cu for Positron Emission Tomography (PET) Imaging

Jai Woong Seo, Hua Zhang, David L. Kukis, +2

Bioconjugate Chemistry

Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: Efficacy and toxicity in breast cancer xenografts

Sally J. DeNardo, David L. Kukis, Linda A. Kroger, +6

Proceedings of the National Academy of Sciences

Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates.

David L. Kukis, Gerald L. DeNardo, Sally J. DeNardo, +4

PubMed

Laboratory ImmunologyImmunologyImmunodominancePathologyImmunologic Mechanism +19

Persistent neuroinflammation and cognitive impairment in a rat model of acute diisopropylfluorophosphate intoxication

Brenna M. Flannery, Donald A. Bruun, Douglas J. Rowland, +9

Journal of Neuroinflammation

High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker with Cyclosporine to Prevent Human Anti-mouse Antibody

Carol M. Richman, Sally J. DeNardo, Robert T. OʼDonnell, +12

Clinical Cancer Research

Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy.

David A. Goodwin, Claude F. Meares, Naoto Watanabe, +7

PubMed

ImmunologyImmunoeditingBalb/c MiceImmunotherapyTumor Uptake +16

A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma.

Robert T. OʼDonnell, Gerald L. DeNardo, David L. Kukis, +7

PubMed